The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Injectable Drug Delivery Devices-Global Market Insights and Sales Trends 2024

Injectable Drug Delivery Devices-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1859269

No of Pages : 115

Ask Your Query
Synopsis
Injectable drug delivery devices are the devices used to administer drugs into the circulatory system. It is the most effective and common route for the administration of most therapeutic agents to ensure a quick response. Injectable drugs are used when patient is unconscious and require quick effect. These devices are majorly used during treatment of diseases like cancer and diabetes.
The global Injectable Drug Delivery Devices market size is expected to reach US$ 10430 million by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The market is mainly driven by the significant applications of Injectable Drug Delivery Devices in various end use industries. The expanding demands from the Immune Disorder, Cancer, Diabetes and Others, are propelling Injectable Drug Delivery Devices market. Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Formulation segment is estimated at % CAGR for the next seven-year period.
Increasing cancer population is the major factor for the growth of the market. Global injectable drug delivery devices market is driven by rising prevalence of chronic diseases, increasing occurrence of needle-stick injuries, increasing use of biologics. Technological advancements, improving patient compliance, beneficial reimbursement policies, increasing healthcare awareness and increasing geriatric population has also contributed to the growth of the market. Whereas, risk of blood-borne infections, safety concerns regarding the use of injectable, introduction of the alternative drug delivery devices would restrain the growth of the market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Injectable Drug Delivery Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Injectable Drug Delivery Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Injectable Drug Delivery Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Injectable Drug Delivery Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Injectable Drug Delivery Devices covered in this report include Dickinson and Company, Baxter International, Schott, Eli Lilly, Pfizer, Gerresheimer, Terumo, Antares Pharma and Novo Nordik, etc.
The global Injectable Drug Delivery Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Dickinson and Company
Baxter International
Schott
Eli Lilly
Pfizer
Gerresheimer
Terumo
Antares Pharma
Novo Nordik
Sanofi
Unilife
Zogenix
Hospira
Presage Bioscience
MicroCHIPS
Pearl Therapeutics
Genentech
Bend Research
Global Injectable Drug Delivery Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Injectable Drug Delivery Devices market, Segment by Type:
Devices
Formulation
Global Injectable Drug Delivery Devices market, by Application
Immune Disorder
Cancer
Diabetes
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Injectable Drug Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Injectable Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Injectable Drug Delivery Devices Market Overview
1.1 Injectable Drug Delivery Devices Product Overview
1.2 Injectable Drug Delivery Devices Market Segment by Type
1.2.1 Devices
1.2.2 Formulation
1.3 Global Injectable Drug Delivery Devices Market Size by Type
1.3.1 Global Injectable Drug Delivery Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Injectable Drug Delivery Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Injectable Drug Delivery Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Injectable Drug Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Injectable Drug Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Injectable Drug Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Injectable Drug Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Injectable Drug Delivery Devices Sales Breakdown by Type (2018-2023)
2 Global Injectable Drug Delivery Devices Market Competition by Company
2.1 Global Top Players by Injectable Drug Delivery Devices Sales (2018-2023)
2.2 Global Top Players by Injectable Drug Delivery Devices Revenue (2018-2023)
2.3 Global Top Players by Injectable Drug Delivery Devices Price (2018-2023)
2.4 Global Top Manufacturers Injectable Drug Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Injectable Drug Delivery Devices Market Competitive Situation and Trends
2.5.1 Injectable Drug Delivery Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Injectable Drug Delivery Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Injectable Drug Delivery Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Injectable Drug Delivery Devices Market
2.8 Key Manufacturers Injectable Drug Delivery Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Injectable Drug Delivery Devices Status and Outlook by Region
3.1 Global Injectable Drug Delivery Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Injectable Drug Delivery Devices Historic Market Size by Region
3.2.1 Global Injectable Drug Delivery Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Injectable Drug Delivery Devices Sales in Value by Region (2018-2023)
3.2.3 Global Injectable Drug Delivery Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Injectable Drug Delivery Devices Forecasted Market Size by Region
3.3.1 Global Injectable Drug Delivery Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Injectable Drug Delivery Devices Sales in Value by Region (2024-2029)
3.3.3 Global Injectable Drug Delivery Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Injectable Drug Delivery Devices by Application
4.1 Injectable Drug Delivery Devices Market Segment by Application
4.1.1 Immune Disorder
4.1.2 Cancer
4.1.3 Diabetes
4.1.4 Others
4.2 Global Injectable Drug Delivery Devices Market Size by Application
4.2.1 Global Injectable Drug Delivery Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Injectable Drug Delivery Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Injectable Drug Delivery Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Injectable Drug Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Injectable Drug Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Injectable Drug Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Injectable Drug Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Injectable Drug Delivery Devices Sales Breakdown by Application (2018-2023)
5 North America Injectable Drug Delivery Devices by Country
5.1 North America Injectable Drug Delivery Devices Historic Market Size by Country
5.1.1 North America Injectable Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Injectable Drug Delivery Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Injectable Drug Delivery Devices Sales in Value by Country (2018-2023)
5.2 North America Injectable Drug Delivery Devices Forecasted Market Size by Country
5.2.1 North America Injectable Drug Delivery Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Injectable Drug Delivery Devices Sales in Value by Country (2024-2029)
6 Europe Injectable Drug Delivery Devices by Country
6.1 Europe Injectable Drug Delivery Devices Historic Market Size by Country
6.1.1 Europe Injectable Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Injectable Drug Delivery Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Injectable Drug Delivery Devices Sales in Value by Country (2018-2023)
6.2 Europe Injectable Drug Delivery Devices Forecasted Market Size by Country
6.2.1 Europe Injectable Drug Delivery Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Injectable Drug Delivery Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Injectable Drug Delivery Devices by Region
7.1 Asia-Pacific Injectable Drug Delivery Devices Historic Market Size by Region
7.1.1 Asia-Pacific Injectable Drug Delivery Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Injectable Drug Delivery Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Injectable Drug Delivery Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Injectable Drug Delivery Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Injectable Drug Delivery Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Injectable Drug Delivery Devices Sales in Value by Region (2024-2029)
8 Latin America Injectable Drug Delivery Devices by Country
8.1 Latin America Injectable Drug Delivery Devices Historic Market Size by Country
8.1.1 Latin America Injectable Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Injectable Drug Delivery Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Injectable Drug Delivery Devices Sales in Value by Country (2018-2023)
8.2 Latin America Injectable Drug Delivery Devices Forecasted Market Size by Country
8.2.1 Latin America Injectable Drug Delivery Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Injectable Drug Delivery Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Injectable Drug Delivery Devices by Country
9.1 Middle East and Africa Injectable Drug Delivery Devices Historic Market Size by Country
9.1.1 Middle East and Africa Injectable Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Injectable Drug Delivery Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Injectable Drug Delivery Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Injectable Drug Delivery Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Injectable Drug Delivery Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Injectable Drug Delivery Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Dickinson and Company
10.1.1 Dickinson and Company Company Information
10.1.2 Dickinson and Company Introduction and Business Overview
10.1.3 Dickinson and Company Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Dickinson and Company Injectable Drug Delivery Devices Products Offered
10.1.5 Dickinson and Company Recent Development
10.2 Baxter International
10.2.1 Baxter International Company Information
10.2.2 Baxter International Introduction and Business Overview
10.2.3 Baxter International Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Baxter International Injectable Drug Delivery Devices Products Offered
10.2.5 Baxter International Recent Development
10.3 Schott
10.3.1 Schott Company Information
10.3.2 Schott Introduction and Business Overview
10.3.3 Schott Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Schott Injectable Drug Delivery Devices Products Offered
10.3.5 Schott Recent Development
10.4 Eli Lilly
10.4.1 Eli Lilly Company Information
10.4.2 Eli Lilly Introduction and Business Overview
10.4.3 Eli Lilly Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly Injectable Drug Delivery Devices Products Offered
10.4.5 Eli Lilly Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Injectable Drug Delivery Devices Products Offered
10.5.5 Pfizer Recent Development
10.6 Gerresheimer
10.6.1 Gerresheimer Company Information
10.6.2 Gerresheimer Introduction and Business Overview
10.6.3 Gerresheimer Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Gerresheimer Injectable Drug Delivery Devices Products Offered
10.6.5 Gerresheimer Recent Development
10.7 Terumo
10.7.1 Terumo Company Information
10.7.2 Terumo Introduction and Business Overview
10.7.3 Terumo Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Terumo Injectable Drug Delivery Devices Products Offered
10.7.5 Terumo Recent Development
10.8 Antares Pharma
10.8.1 Antares Pharma Company Information
10.8.2 Antares Pharma Introduction and Business Overview
10.8.3 Antares Pharma Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Antares Pharma Injectable Drug Delivery Devices Products Offered
10.8.5 Antares Pharma Recent Development
10.9 Novo Nordik
10.9.1 Novo Nordik Company Information
10.9.2 Novo Nordik Introduction and Business Overview
10.9.3 Novo Nordik Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Novo Nordik Injectable Drug Delivery Devices Products Offered
10.9.5 Novo Nordik Recent Development
10.10 Sanofi
10.10.1 Sanofi Company Information
10.10.2 Sanofi Introduction and Business Overview
10.10.3 Sanofi Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sanofi Injectable Drug Delivery Devices Products Offered
10.10.5 Sanofi Recent Development
10.11 Unilife
10.11.1 Unilife Company Information
10.11.2 Unilife Introduction and Business Overview
10.11.3 Unilife Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Unilife Injectable Drug Delivery Devices Products Offered
10.11.5 Unilife Recent Development
10.12 Zogenix
10.12.1 Zogenix Company Information
10.12.2 Zogenix Introduction and Business Overview
10.12.3 Zogenix Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Zogenix Injectable Drug Delivery Devices Products Offered
10.12.5 Zogenix Recent Development
10.13 Hospira
10.13.1 Hospira Company Information
10.13.2 Hospira Introduction and Business Overview
10.13.3 Hospira Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Hospira Injectable Drug Delivery Devices Products Offered
10.13.5 Hospira Recent Development
10.14 Presage Bioscience
10.14.1 Presage Bioscience Company Information
10.14.2 Presage Bioscience Introduction and Business Overview
10.14.3 Presage Bioscience Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Presage Bioscience Injectable Drug Delivery Devices Products Offered
10.14.5 Presage Bioscience Recent Development
10.15 MicroCHIPS
10.15.1 MicroCHIPS Company Information
10.15.2 MicroCHIPS Introduction and Business Overview
10.15.3 MicroCHIPS Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.15.4 MicroCHIPS Injectable Drug Delivery Devices Products Offered
10.15.5 MicroCHIPS Recent Development
10.16 Pearl Therapeutics
10.16.1 Pearl Therapeutics Company Information
10.16.2 Pearl Therapeutics Introduction and Business Overview
10.16.3 Pearl Therapeutics Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Pearl Therapeutics Injectable Drug Delivery Devices Products Offered
10.16.5 Pearl Therapeutics Recent Development
10.17 Genentech
10.17.1 Genentech Company Information
10.17.2 Genentech Introduction and Business Overview
10.17.3 Genentech Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Genentech Injectable Drug Delivery Devices Products Offered
10.17.5 Genentech Recent Development
10.18 Bend Research
10.18.1 Bend Research Company Information
10.18.2 Bend Research Introduction and Business Overview
10.18.3 Bend Research Injectable Drug Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Bend Research Injectable Drug Delivery Devices Products Offered
10.18.5 Bend Research Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Injectable Drug Delivery Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Injectable Drug Delivery Devices Industrial Chain Analysis
11.4 Injectable Drug Delivery Devices Market Dynamics
11.4.1 Injectable Drug Delivery Devices Industry Trends
11.4.2 Injectable Drug Delivery Devices Market Drivers
11.4.3 Injectable Drug Delivery Devices Market Challenges
11.4.4 Injectable Drug Delivery Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Injectable Drug Delivery Devices Distributors
12.3 Injectable Drug Delivery Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock